AU2003209459A1 - Protein-protein interactions in human tumours involving bcmp-7 and bcmp-11 - Google Patents

Protein-protein interactions in human tumours involving bcmp-7 and bcmp-11

Info

Publication number
AU2003209459A1
AU2003209459A1 AU2003209459A AU2003209459A AU2003209459A1 AU 2003209459 A1 AU2003209459 A1 AU 2003209459A1 AU 2003209459 A AU2003209459 A AU 2003209459A AU 2003209459 A AU2003209459 A AU 2003209459A AU 2003209459 A1 AU2003209459 A1 AU 2003209459A1
Authority
AU
Australia
Prior art keywords
bcmp
protein
human tumours
involving
interactions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003209459A
Other versions
AU2003209459A8 (en
Inventor
Laurent Daviet
Pierre Legrain
Jonathan Alexander Terrett
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hybrigenics SA
Oxford Glycosciences UK Ltd
Original Assignee
Hybrigenics SA
Oxford Glycosciences UK Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hybrigenics SA, Oxford Glycosciences UK Ltd filed Critical Hybrigenics SA
Publication of AU2003209459A1 publication Critical patent/AU2003209459A1/en
Publication of AU2003209459A8 publication Critical patent/AU2003209459A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57415—Specifically defined cancers of breast
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Food Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AU2003209459A 2002-03-06 2003-03-06 Protein-protein interactions in human tumours involving bcmp-7 and bcmp-11 Abandoned AU2003209459A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP02290560.8 2002-03-06
EP02290560 2002-03-06
PCT/GB2003/000931 WO2003075014A2 (en) 2002-03-06 2003-03-06 Protein-protein interactions in human tumours involving bcmp-7 and bcmp-11

Publications (2)

Publication Number Publication Date
AU2003209459A1 true AU2003209459A1 (en) 2003-09-16
AU2003209459A8 AU2003209459A8 (en) 2003-09-16

Family

ID=27771955

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003209459A Abandoned AU2003209459A1 (en) 2002-03-06 2003-03-06 Protein-protein interactions in human tumours involving bcmp-7 and bcmp-11

Country Status (2)

Country Link
AU (1) AU2003209459A1 (en)
WO (1) WO2003075014A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1762575A1 (en) * 2005-09-12 2007-03-14 Ganymed Pharmaceuticals AG Identification of tumor-associated antigens for diagnosis and therapy
GB0616929D0 (en) * 2006-08-26 2006-10-04 Univ Liverpool Antibodies, assays and hybridomas
EP1970384A1 (en) 2007-03-14 2008-09-17 Ganymed Pharmaceuticals AG Monoclonal antibodies for treatment of cancer
EP2166021A1 (en) 2008-09-16 2010-03-24 Ganymed Pharmaceuticals AG Monoclonal antibodies for treatment of cancer
EP2371864A1 (en) 2010-03-23 2011-10-05 Ganymed Pharmaceuticals AG Monoclonal antibodies for treatment of cancer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0004576D0 (en) * 2000-02-25 2000-04-19 Oxford Glycosciences Uk Ltd Proteins
CA2399999A1 (en) * 2000-02-25 2001-08-30 Oxford Glycosciences (Uk) Ltd. Use of breast cancer associated membrane proteins (bcmp) for treatment, prophylaxis and diagnosis of breast cancer

Also Published As

Publication number Publication date
AU2003209459A8 (en) 2003-09-16
WO2003075014A2 (en) 2003-09-12
WO2003075014A3 (en) 2003-12-24

Similar Documents

Publication Publication Date Title
AU2003293376A1 (en) Anti-angiogenic compounds and their use in cancer treatment
IL172316A0 (en) Novel compounds and their use in therapy
IL174994A0 (en) Pyrimidin - 4 - yl - 3, 4 - thione compounds and their use in therapy
AU2003262865A1 (en) Systems and methods for use in mobile medical training
AU2003215460A8 (en) Cancer associated protein kinases and their uses
AU2003255544A1 (en) Tumor specific oligosaccharide epitopes and use thereof
AU2002346288A1 (en) Plypropylene fabric and its use in the personal care field
AU2003227861A1 (en) Protein involved in cancer
AU2003209459A1 (en) Protein-protein interactions in human tumours involving bcmp-7 and bcmp-11
SG110107A1 (en) Compound and use in treatment
AU2003207628A1 (en) Structural and cytoskeleton-associated proteins
AU2003280648A1 (en) Cosmetics excellent in texture and oil-dispersibility
AU2003284597A1 (en) Apoptosis-associated protein and use thereof
AU2003234140A1 (en) Aziridine compounds and their use in medical devices
AU2003240446A1 (en) Use of mob-5 in pain
AU2003240253A1 (en) Polymorphisms in the human gene for htr3b and their use in diagnostic and therapeutic applications
AU2003301759A1 (en) Human vps4a and vps4b functions in viral budding
AU2003211710A1 (en) K+ transporter and use thereof
AU2003224147A1 (en) Pax-5-deficient pro-b-cells, methods of producing them and the use of such cells in human therapy
AU2002360082A1 (en) Human autoantigens and use thereof
AU2003255232A1 (en) Antigiardial agents and use thereof
AU2003902089A0 (en) Improvements in mechanisms and devices
GB0203043D0 (en) Benzimidazloe compounds their preparation and their use in therapy
GB0203042D0 (en) Anthraquinine compounds their preparation and their use in therapy
GB0324205D0 (en) Piperidinyl-diarylsilanol compounds and their use in threrapy

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase